Previous Close | 17.50 |
Open | 17.26 |
Bid | 17.10 x 800 |
Ask | 17.30 x 1000 |
Day's Range | 16.67 - 18.00 |
52 Week Range | 5.31 - 21.50 |
Volume | |
Avg. Volume | 2,207,751 |
Market Cap | 940.864M |
Beta (5Y Monthly) | 1.82 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Investors looking for growth stocks that can make dramatic moves in a short time should look more closely at healthcare. The phase 2 trial tried four dosage strengths, and even the lowest dose led to liver-fat reduction of 30% or better for a majority of patients.
Q1 2023 Nano-X Imaging Ltd Earnings Call
Shares of Nano-X Imaging (NASDAQ: NNOX), also known as Nanox, popped off more gains on Monday after the medical imaging device company reported financial results for the first quarter of 2023. As of 3:40 p.m. ET, Nanox stock was up 11%. Nanox is a very early stage company.
Earlier today, Nano-X Imaging Limited released financial results for the quarter ended March 31, 2023. Erez Meltzer, chief executive officer; and Ran Daniel, chief financial officer, will host this morning's call.
Shares of start-up medical-imaging technology company Nano-X Imaging (NASDAQ: NNOX), or simply Nanox, jumped again on Thursday after it was announced that a major healthcare company increased its investment in the company. As of 3:40 p.m. ET, Nanox stock was up a whopping 17% for today's session and is now up more than 200% in May alone. Johnson & Johnson (NYSE: JNJ) is a behemoth in the healthcare space and, as it turns out, it's an investor in Nanox stock.
With the business potentially at an important milestone, we thought we'd take a closer look at Nano-X Imaging Ltd.'s...
The medical technology company has a new product with exciting potential -- but whether that will translate into profitable sales is less clear.
They don't always portend disaster, but you can avoid creating a disaster by knowing what to watch for.
Well, Nano-X Imaging's (NASDAQ: NNOX) stock is soaring at the moment, with its shares blasting off by 165% in the last 30 days. Here's what you need to know about Nano-X Imaging before considering whether to buy it. To make its product even more accessible to that market, the company is also pioneering a novel business model in which it only charges customers for the scans they run, rather than for the capital cost of the X-ray equipment.
Nano-X Imaging Ltd. (NNOX) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Shares of medical technology company Nano-X Imaging (NASDAQ: NNOX), also known as Nanox, skyrocketed on Monday after the company received clearance from the Food and Drug Administration (FDA) for its flagship medical device. As of 10:30 a.m. ET, Nanox stock was up by a whopping 60%. Nanox intends to disrupt the world of X-ray technology with a medical imaging device that it says provides 3D digital images for a fraction of the cost of previously available technologies.
Nano-X Imaging (NASDAQ: NNOX) stock may be down 13% so far this year, but some see a much brighter future for the maker of digital x-ray equipment. Wall Street analysts are estimating that the stock will surge by an incredible 358% this year. It's special because it uses a digital x-ray source that's allegedly cheaper to use, less expensive to maintain, smaller, and easier to use than traditional analog ray sources.
It's easy to match the overall market return by buying an index fund. While individual stocks can be big winners...
Q4 2022 Nano-X Imaging Ltd Earnings Call
Earlier today, Nano-X Imaging Limited released its financial results for the quarter ended December 31, 2022. Erez Meltzer, chief executive officer, and Ran Daniel, chief financial officer, will host this morning's call.
The Ledger Stax is a stylish device that features an e-ink display that can show transaction details and even NFTs on its exterior.
Earlier today, NANO-X IMAGING, LTD. released its financial results for the quarter ended September 30, 2022. Erez Meltzer, chief executive officer; and Ran Daniel, chief financial officer, will host this morning's call.
Taking the occasional loss comes part and parcel with investing on the stock market. And unfortunately for Nano-X...
Shares of Nano-X Imaging (NASDAQ: NNOX), commonly called Nanox, soared on Wednesday after it revealed it's taken the next step toward commercializing its flagship medical device. As of 12:20 p.m. ET, Nanox stock was up 21%. Nanox had its initial public offering (IPO) in 2020, promising to disrupt the X-ray industry with its digital-3D imaging machines that will be cheaper for doctors to use.
One of the big advantages individual investors have over fund managers is that no one is looking over their shoulders for quick results. In this roundtable, three Motley Fool contributors picked healthcare stocks that they believe will be big winners for a long time. Here's why they recommend OrthoPediatrics (NASDAQ: KIDS), Compass Pathways (NASDAQ: CMPS), and Nano-X Imaging (NASDAQ: NNOX).
Earlier today, Nano-X Imaging Limited released its financial results for the quarter ended June 30, 2022. Erez Meltzer, chief executive officer; and Ran Daniel, chief financial officer, will host this morning's call. Before we get started, I would like to remind everyone that management will be making statements during this call that include forward-looking statements regarding the company's financial results, research and development, manufacturing and commercialization activities, regulatory process operations, and other matters.
Every investor in Nano-X Imaging Ltd. ( NASDAQ:NNOX ) should be aware of the most powerful shareholder groups...
Investing in biotech stocks without any drugs on the market can be scary. These suggestions can help you make money in this high-risk sector.
Contrarian investing is fun because when you nail a contrarian pick correctly, you get the joy of saying "I told you so!" Seeing the value in opportunities that other investors discard means capturing outsized profits when things go right. Nano-X's product in development is the Nanox.ARC, an X-ray imaging device that's significantly less expensive to operate than traditional X-ray machines used in hospitals worldwide thanks to its innovative low-cost X-ray tubes. The idea is that when paired with the company's artificial intelligence (AI) software package, remote clinics in economically disadvantaged areas that might not have enough money for an X-ray machine or a radiologist can use the Nanox.ARC and pay Nano-X for each scan they perform.